At Matice Biosciences, we’re driven by a vision to outsmart one of the most deadly biological challenges: fibrosis. By harnessing the power of AI and multi-omic insights from nature’s most potent regenerators, we’ve built a biotechnology platform that designs and optimizes peptide-based solutions to combat fibrosis.

Achieved first in the world regulatory approval of cultivated chicken in Singapore in 2020. Also, achieved first regulatory approval of cultivated chicken using serum-free medium as well as FDA and USDA approvals in 2023.Development, scale-up and routine manufacturing of protein isolate from mung beans used in Just Egg. Responsible for brown field site identification and development to house new protein isolation technology, capable of several million pounds per year capacity.

Responsible for the manufacture and development of licensed and investigational vaccines, including diphtheria, tetanus, acellular pertussis and Haemophilus influenzae type b-tetanus conjugated vaccines. Accountable for manufacturing facility and supply chain management.

Managed fermentation and cell culture development group for an array of projects. Served as project leader for Humira process development program: 1) coordinated and supervised interdisciplinary team responsible for transfection and amplification of human MAbs in multiple cell lines, 2) developed lab-scale cell culture process and scaled process to manufacturing scale.

Development of a perfusion-based process for attenuated hepatitis A virus production